<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/58930F3F-9B16-4DC2-833F-C72033E77A1E"><gtr:id>58930F3F-9B16-4DC2-833F-C72033E77A1E</gtr:id><gtr:name>Boston Children's Hospital</gtr:name><gtr:address><gtr:line1>Boston Childrens Hospital</gtr:line1><gtr:line2>Karp Building</gtr:line2><gtr:line3>9th floor, Rm 09210 1 Blackfan Circle</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Oncology</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/58930F3F-9B16-4DC2-833F-C72033E77A1E"><gtr:id>58930F3F-9B16-4DC2-833F-C72033E77A1E</gtr:id><gtr:name>Boston Children's Hospital</gtr:name><gtr:address><gtr:line1>Boston Childrens Hospital</gtr:line1><gtr:line2>Karp Building</gtr:line2><gtr:line3>9th floor, Rm 09210 1 Blackfan Circle</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1B52B94A-9456-4176-B6D1-1A4415548D28"><gtr:id>1B52B94A-9456-4176-B6D1-1A4415548D28</gtr:id><gtr:firstName>Anna</gtr:firstName><gtr:surname>Philpott</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0700758"><gtr:id>232A57A8-8A20-4EC0-99A9-3FC159C08FA6</gtr:id><gtr:title>Neurogenin 3: regulation of protein stability.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700758</gtr:grantReference><gtr:abstractText>Diabetes results from loss or inactivity of cells, called islet cells, that produce insulin. One of the ways that we could treat diabetes is by replacing these cells using stem cells that have been instructed to turn into islets. Neurogenin 3 (NGN3) is a protein that drives formation of islets and the amount of NGN3 protein present in very important. We have found that NGN3 protein is unstable and is rapidly destroyed in the cells of the body. This proposal aims to look at the ways this destruction is controlled. When we understand this, we can make altered forms of NGN3 that are resistant to being broken down. In these intial studies, we will inject these stable forms of NGN3 into tadpoles to see if they are, indeed, present at higher levels and are, therefore, more active that the original protein. Tadpoles are excellent for this study as they are large, develop outside the mother and are easy to inject proteins into. Moreover, we already know that tadpoles respond to normal NGN3 so act as a useful system to test for increased NGN3 activity. We will then see if our altered NGN3s are also stable in mammalian cells in culture. 
 These studies will pave the way for experiments to see if stabilised NGN3 can be added back to stem cells to encourage them to form islets. If we can find a way to re-supply islet cells to diabetic patients, this may be an effective therapy to stabilise blood sugar levels and reduce the severity of symptoms and morbidity resulting from diabetes, one of the greatest public health concerns of the 21st Century.</gtr:abstractText><gtr:technicalSummary>Diabetes, caused by a loss or inactivity of beta islet cells in the pancreas, is a major cause of illness and mortality worldwide. The basic helix-loop-helix (bHLH) transcription factor Neurogenin 3 (NGN3) drives decision to adopt an endocrine over an exocrine cell fate during development of the pancreas. Indeed, the absolute level of NGN3 is a central regulator of endocrine differentiation, and if levels of NGN3 are elevated at the appropriate time, the number of cells adopting an insulin-expressing fate is dramatically increased. For this reason, manipulation of NGN3 activity is a focus of considerable interest to researchers who are attempting to promote stem cells in culture to adopt an endocrine pancreatic fate, potentially driving differentiation of islets for diabetes therapy. Here we present preliminary data showing the first evidence that the level of active NGN3 is regulated by control of protein stability via the ubiquitin-proteosome system.
Building on unpublished work about the related NGN2 protein and further preliminary findings on the NGN3 protein, the aims of this proposal are three-fold. Firstly firstly we will confirm that NGN3 is degraded by Ubiquitin-mediated proteolysis using Xenopus egg extracts asa biochemical system, alongside studies of NGN3 degradation in mammalian cultured cells. Secondly we will define sites of poly-ubiquitination of NGN3 and explore how this process is regulated by phosphorylation. Thirdly, we will use this information to test the activity of stabilised forms of NGN3 in reporter assays, in cultured cells and in vivo in Xenopus embryos. These studies will allow us not only to define pathways that regulate NGN3 stability, but also to to design forms of NGN3 that are resistant to degradation. In the future, building on work proposed here, we will be able to test the effects of stablising NGN3 on endocrine pancreas formation in in vivo models and stem cells, potentially leading to new therapeutic approaches to treatment of diabetes.</gtr:technicalSummary><gtr:fund><gtr:end>2011-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>276602</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard Medical School</gtr:department><gtr:description>In vitro assays for cdk phosphorylation</gtr:description><gtr:id>7FEACDD7-AE5D-439D-A841-CDCFD89FAE9A</gtr:id><gtr:impact>Primary research publication.</gtr:impact><gtr:outcomeId>SFHAsFdobPa-1</gtr:outcomeId><gtr:partnerContribution>Undertook biochemical analysis of our mutanats, providing crucial data for a co-authored publication.</gtr:partnerContribution><gtr:piContribution>We provided conceptual ideas and experimental materials</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Boston Children's Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Multi-site modification analysis of Ngn</gtr:description><gtr:id>78126689-30EB-417C-AE12-9314A25A2651</gtr:id><gtr:impact>A collaborative travel grant was obtained from the Foreign Office to set up this collaboration. We have undertaken 2 more visits to Boston and have written a grant application to BBSRC to fund this collaboration. I am also now a collaborator on an NIH-funded project of Prof Steen. This collaboration is multi-disciplinary, involving in vivo analysis, protein biochemistry, Mass Spectrometry and mathematical systems biology.</gtr:impact><gtr:outcomeId>b3qJQM6dwch-1</gtr:outcomeId><gtr:partnerContribution>Prof HS is undertaking Multi-site Mass Spectrometry analyses of samples we provide him to use cutting-edge technology for quantitating phsophorylation on individual sites</gtr:partnerContribution><gtr:piContribution>We are providing samples for Mass Spec and systems biology-based analysis of the role of multi-site modification of Ngn function</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>Post-translational modification of proneural proteins</gtr:description><gtr:id>54F80EBF-151E-49FB-84F0-368586B864A8</gtr:id><gtr:impact>We have submitted a joint grant application (unsuccessful) and have published a co-authored primary publication.</gtr:impact><gtr:outcomeId>j2QCBfCnncs-1</gtr:outcomeId><gtr:partnerContribution>My collaborator is using our data generated in Xenopus to extrapolate to the developing mouse and we are currently preparing two co-authored publications.</gtr:partnerContribution><gtr:piContribution>We provided experimental data from Xenopus and cultured cells and crucial conceptual imputs.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wellcome Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Trust Centre for Stem Cell Research</gtr:department><gtr:description>Assaying function of NGN3 mutants in ES cells</gtr:description><gtr:id>97008C80-E502-4FDC-A943-0E57FE2268A2</gtr:id><gtr:impact>Joint grant application to be submitted in 2012. New techniques introduced to the lab after my sabbatical visit.</gtr:impact><gtr:outcomeId>F2B19EF30C1-1</gtr:outcomeId><gtr:partnerContribution>Joint grant application was submitted in Jan 2011 on work arising from this grant that can now be extended into study of ES cell behaviour but was not funded. A reworked grant application will be submitted 2012.</gtr:partnerContribution><gtr:piContribution>Preliminary data generated on the effect of posttranslational modification of NGN3 indicates that manipulation in ES cells may be beneficial for generation of pancreatic lineages. We will test this out in ES cells that are induced to differentiate into endoderm if our grant application is successful.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>12000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Small grant</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Rosetrees Trust</gtr:fundingOrg><gtr:id>69B52084-E2D5-491E-BF01-7A8D3BF36775</gtr:id><gtr:outcomeId>hjxd7nutZmR</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>172000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>project grant</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>The Neuroblastoma Society</gtr:fundingOrg><gtr:id>DAF5118E-CCFC-4AAB-85A2-0D9A8B47C5F0</gtr:id><gtr:outcomeId>eJJdLAFh23z</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>110000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>The Neuroblastoma Society</gtr:fundingOrg><gtr:id>E4E2D9C4-072C-456C-ADCF-62C63980E311</gtr:id><gtr:outcomeId>so2ruifjMYJ</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>12000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Small grant</gtr:description><gtr:end>2013-01-02</gtr:end><gtr:fundingOrg>Rosetrees Trust</gtr:fundingOrg><gtr:id>601D9B9A-A208-4053-90A0-0118F75421CE</gtr:id><gtr:outcomeId>bHoA2zLbif4</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>43000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Centenary award</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>ACF794BB-BA61-40D8-B9A9-2AEA47947B28</gtr:id><gtr:outcomeId>MhPFKetbhdo</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>using kinase inhibitors, we can enhance the ability of bHLH transcription factors to drive differentiation in a number of tissues including neutrons and pancreatic islets. This is useful for disease modelling and has the potential to improve generation of pancreatic islets for transplantation.</gtr:description><gtr:grantRef>G0700758</gtr:grantRef><gtr:id>6155649B-C4AD-4F9C-B6BE-028A239D1EDE</gtr:id><gtr:impact>None yet, although the methodology is in development in my lab still.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>56cdc11565a494.06617260</gtr:outcomeId><gtr:patentId>PCT/EP2013/068511</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>maturation of mammalian cells by modulation of protein phosphorylation</gtr:title><gtr:yearProtectionGranted>2013</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Multisite phosphomutant Ngn2 proteins have been generated an an assay for neurogenic activity in vivo has been set up in Xenopus.</gtr:description><gtr:id>C48BF275-59D7-4301-B35A-10E2522A4173</gtr:id><gtr:impact>These materials have allowed comparison with regulation of other proneural proteins to show conservation of regulatory mechanisms across this important protein family.</gtr:impact><gtr:outcomeId>atbyJ5feea2</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Phosphomutant proneural series for testing in Xenopus embryos</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>New assay methods for Ubiquitin-mediated proteolysis in Xenopus eggs and embryos</gtr:description><gtr:id>AD4044D7-C2D5-4885-8711-D336A4EF8DB5</gtr:id><gtr:impact>fast screening of the degradation of proteins and modified proteins to look at stability/unfoldability rapidly, looking at both canonical and novel non-canonical modes of ubiquitination.</gtr:impact><gtr:outcomeId>44409CDD494</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Cysteine ubiquitination assay</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>DBB287C4-ACDB-4BF6-A9D2-4DD355C3A322</gtr:id><gtr:title>The phosphorylation status of Ascl1 is a key determinant of neuronal differentiation and maturation in vivo and in vitro.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa282898cbf0ed8a4679b0bacbd4824a"><gtr:id>aa282898cbf0ed8a4679b0bacbd4824a</gtr:id><gtr:otherNames>Ali FR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>pm_540e155e1550885cc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5220EAF4-D56B-4CCA-A582-2F441D19AD9A</gtr:id><gtr:title>Non-canonical ubiquitylation of the proneural protein Ngn2 occurs in both Xenopus embryos and mammalian cells.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/430fcb4eb3500fa5cf1c801d36bd7bf0"><gtr:id>430fcb4eb3500fa5cf1c801d36bd7bf0</gtr:id><gtr:otherNames>McDowell GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>VQnSAAMbyxp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8E997EA-1925-4012-9437-FE6E3BCD2E55</gtr:id><gtr:title>Phosphorylation in intrinsically disordered regions regulates the activity of Neurogenin2.</gtr:title><gtr:parentPublicationTitle>BMC biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/430fcb4eb3500fa5cf1c801d36bd7bf0"><gtr:id>430fcb4eb3500fa5cf1c801d36bd7bf0</gtr:id><gtr:otherNames>McDowell GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2091</gtr:issn><gtr:outcomeId>doi_55f9849846b90080</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BFF4544-6E11-48B8-85BE-AC15C8C346A5</gtr:id><gtr:title>Ubiquitylation on canonical and non-canonical sites targets the transcription factor neurogenin for ubiquitin-mediated proteolysis.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/376c687cf44bb401ebcfab6c62dac9ea"><gtr:id>376c687cf44bb401ebcfab6c62dac9ea</gtr:id><gtr:otherNames>Vosper JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>CAbjZGzJXSS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16E0C9DB-6CDF-4B44-8248-857E639552AD</gtr:id><gtr:title>Co-ordination of cell cycle and differentiation in the developing nervous system.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/648faf2253b9e0aa9d491977cf84114f"><gtr:id>648faf2253b9e0aa9d491977cf84114f</gtr:id><gtr:otherNames>Hindley C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_13548_28_22642576</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F59ACC0B-973D-4625-BCC8-DA4394B0C31B</gtr:id><gtr:title>Hes6 is required for the neurogenic activity of neurogenin and NeuroD.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f8a3023168b3dc24da0da2d9d15bd6d"><gtr:id>5f8a3023168b3dc24da0da2d9d15bd6d</gtr:id><gtr:otherNames>Murai K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13548_28_22114720</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>216CB4E2-4E3B-44BF-BCC9-1E7825F92DCE</gtr:id><gtr:title>Complex domain interactions regulate stability and activity of closely related proneural transcription factors.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/430fcb4eb3500fa5cf1c801d36bd7bf0"><gtr:id>430fcb4eb3500fa5cf1c801d36bd7bf0</gtr:id><gtr:otherNames>McDowell GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>doi_55f9849846adbe90</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2005907E-056C-44CA-96F2-98D9CC44735B</gtr:id><gtr:title>The F-box protein Cdc4/Fbxw7 is a novel regulator of neural crest development in Xenopus laevis.</gtr:title><gtr:parentPublicationTitle>Neural development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/324714ef032f0bb8bfd33fa8127cf417"><gtr:id>324714ef032f0bb8bfd33fa8127cf417</gtr:id><gtr:otherNames>Almeida AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1749-8104</gtr:issn><gtr:outcomeId>1AA93A61239</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABB189BD-8EEE-41B4-A17E-915957F0EBB8</gtr:id><gtr:title>Cell cycle regulation of proliferation versus differentiation in the central nervous system.</gtr:title><gtr:parentPublicationTitle>Cell and tissue research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e3bd53c935f643aab5b8c97e7f6e3f0"><gtr:id>3e3bd53c935f643aab5b8c97e7f6e3f0</gtr:id><gtr:otherNames>Hardwick LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0302-766X</gtr:issn><gtr:outcomeId>doi_55f9849846a58f77</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4988FA0-279A-4518-AEA9-616709BFEF7C</gtr:id><gtr:title>Nervous decision-making: to divide or differentiate.</gtr:title><gtr:parentPublicationTitle>Trends in genetics : TIG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e3bd53c935f643aab5b8c97e7f6e3f0"><gtr:id>3e3bd53c935f643aab5b8c97e7f6e3f0</gtr:id><gtr:otherNames>Hardwick LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0168-9525</gtr:issn><gtr:outcomeId>pm_540e154e154fe7da1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3AF4D307-4616-4D28-A037-2A7668BB7B77</gtr:id><gtr:title>Post-translational modification of Ngn2 differentially affects transcription of distinct targets to regulate the balance between progenitor maintenance and differentiation.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/648faf2253b9e0aa9d491977cf84114f"><gtr:id>648faf2253b9e0aa9d491977cf84114f</gtr:id><gtr:otherNames>Hindley C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>pm_13548_28_22491944</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>816E2F45-7FA5-421F-838D-95BE06EA4E83</gtr:id><gtr:title>Complex regulation controls Neurogenin3 proteolysis.</gtr:title><gtr:parentPublicationTitle>Biology open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f26e929861b28361d5485614d97602e8"><gtr:id>f26e929861b28361d5485614d97602e8</gtr:id><gtr:otherNames>Roark R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2046-6390</gtr:issn><gtr:outcomeId>pm_13548_28_23259061</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78A3F93C-B965-49DD-B4EB-F41FFC4DAD16</gtr:id><gtr:title>Cell cycle-regulated multi-site phosphorylation of Neurogenin 2 coordinates cell cycling with differentiation during neurogenesis.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/290f9b2af8fda4b3d4d6e83c82465b3d"><gtr:id>290f9b2af8fda4b3d4d6e83c82465b3d</gtr:id><gtr:otherNames>Ali F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>56c45a4f466219.54115720</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78B78E53-9487-4E4B-9D35-A2DA29772B8C</gtr:id><gtr:title>New Insights Into the Role of Ubiquitylation of Proteins.</gtr:title><gtr:parentPublicationTitle>International review of cell and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/430fcb4eb3500fa5cf1c801d36bd7bf0"><gtr:id>430fcb4eb3500fa5cf1c801d36bd7bf0</gtr:id><gtr:otherNames>McDowell GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1937-6448</gtr:issn><gtr:outcomeId>5a3248de9f0682.33313095</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA575CF4-3007-4B01-8C31-D4640B6A528E</gtr:id><gtr:title>The cell cycle and pluripotency.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/648faf2253b9e0aa9d491977cf84114f"><gtr:id>648faf2253b9e0aa9d491977cf84114f</gtr:id><gtr:otherNames>Hindley C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_13548_28_23535166</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4AC93947-923E-4688-AEAD-3686976FCF53</gtr:id><gtr:title>Neuroblastoma progress on many fronts: the Neuroblastoma Research Symposium.</gtr:title><gtr:parentPublicationTitle>Pediatric blood &amp; cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/596b490b9715df19e127b32bec9ad80c"><gtr:id>596b490b9715df19e127b32bec9ad80c</gtr:id><gtr:otherNames>Wylie L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1545-5009</gtr:issn><gtr:outcomeId>doi_55f984984691ffb3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC2395A7-E730-49EA-A3AD-F52F0D976461</gtr:id><gtr:title>Regulation of cell fate determination by Skp1-Cullin1-F-box (SCF) E3 ubiquitin ligases.</gtr:title><gtr:parentPublicationTitle>The International journal of developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8642ef95abc74892ecb4a11f9f2bc862"><gtr:id>8642ef95abc74892ecb4a11f9f2bc862</gtr:id><gtr:otherNames>Hindley CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0214-6282</gtr:issn><gtr:outcomeId>doi_55f9849846c55728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1588926E-8E25-43BF-8282-5BFCAFAB45AD</gtr:id><gtr:title>Emergence of neuronal diversity from patterning of telencephalic progenitors.</gtr:title><gtr:parentPublicationTitle>Wiley interdisciplinary reviews. Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f26d54a3ced3310bae19e29b38dd4bd"><gtr:id>2f26d54a3ced3310bae19e29b38dd4bd</gtr:id><gtr:otherNames>Azzarelli R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1759-7684</gtr:issn><gtr:outcomeId>5675defb240e0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>669FE5BA-83DF-4021-A662-C92DB40AA9DD</gtr:id><gtr:title>Non-canonical ubiquitylation: mechanisms and consequences.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/430fcb4eb3500fa5cf1c801d36bd7bf0"><gtr:id>430fcb4eb3500fa5cf1c801d36bd7bf0</gtr:id><gtr:otherNames>McDowell GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>pm_13548_28_23732108</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A4A8FFA-B857-4EA1-9F0C-AAD70C7107AB</gtr:id><gtr:title>An oncologist?s friend: How Xenopus contributes to cancer research.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e3bd53c935f643aab5b8c97e7f6e3f0"><gtr:id>3e3bd53c935f643aab5b8c97e7f6e3f0</gtr:id><gtr:otherNames>Hardwick LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>56bdf519866131.61718262</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700758</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>